Philips and Spencer Health Solutions expand partnership to Europe
14 Ottobre 2019 - 2:00PM
Philips and Spencer Health Solutions expand partnership to Europe
October 14, 2019
Chronically ill patients in selected EU countries to benefit
from in-home medication adherence and telehealth platform
Amsterdam, the Netherlands and Morrisville, NC,
U.S. – Building on their successful partnership providing
medication adherence solutions to high-acuity patients in the U.S.
Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health
technology, and Spencer Health Solutions announced today the
expansion of their partnership to Europe.
Technological solutions can help patients and their caregivers
to improve medication plan compliance. Medication adherence reduces
hospitalization, emergency department use and doctor’s visits of
patients and thereby lessens this burden on healthcare systems
leading to lower healthcare costs [1,2]. Estimates suggest that
non-adherence contributes to nearly 200,000 premature deaths in
Europe and costs of EUR 125 billion annually in excess healthcare
services for European Governments [2].
“As health systems work to better manage high risk and high-cost
patient populations, medication adherence solutions can help to
improve medication management and increase patient engagement,”
said Derek Ross, Business Leader Population Health Management at
Philips. “Technological solutions can help our customers to improve
medication adherence of their patients and to deliver better
value-based care. We are excited to bring a user-friendly and
patient-centric solution for medication adherence to Europe
together with Spencer Health Solutions.”
Already in use by patients taking multiple medications in the
United States and Canada, the Spencer® Smart Hub is launching in
selected markets in Europe including Austria, Belgium, Germany,
Luxembourg, Netherlands and Switzerland, beginning with the
Netherlands in the fourth quarter of 2019. The Spencer medication
adherence solution is part of a portfolio of Philips solutions to
support and remotely manage elderly and patients in their homes and
connect them with their care providers when needed.
“Through our partnership with Philips we can now jointly
introduce our medication adherence solution into the homes of
patients across Europe,” said Tom Rhoads, CEO of Spencer. “This
expansion builds on our existing partnership in the U.S. which
benefits care providers and patients by improving medication
adherence. Our digital solution, that connects patients and care
providers, supports the delivery of medicine and proactive care
while driving down the costs of medical complications related to
non-adherence.”
The Spencer device offers a connected ecosystem: an in-home
dispensing device providing pre-packaged unit dose medication, a
connection to the pharmacy and an assist app for family and
caregivers. Family and caregivers are notified and able to contact
the patient, when the patient does not take medication. The
platform has high rates of medication adherence and patient
engagement in the U.S. A case study shows an average adherence rate
for patients using Spencer greater than 95 percent, and an average
patient response rate to health status questions presented with
medication dispenses greater than 81 percent [3].
[1] Roebuck, M.C. et al., Medication adherence leads to lower
health care use and costs despite increased drug spending. Health
Affairs, 2011, Jan;30(1):91-99. [2] OECD (2018) Investing in
medication adherence improves health outcomes and health system
efficiency – Available at:
http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=DELSA/HEA/WD/HWP(2018)2&docLanguage=En
Last accessed: 13 September[3] Spencer whitepaper
For further information, please contact
Joost MalthaPhilips Global Press OfficeTel.: +31 6 10 55 81
16E-mail: joost.maltha@philips.com
Gayle McCrackenSpencer Health Solutions, Inc.Tel.: +1
919-208-9176E-mail:
gmccracken@spencerhealthsolutions.comAbout Royal
PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is a leading
health technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2018
sales of EUR 18.1 billion and employs approximately 78,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
About Spencer Health SolutionsAdvancing
research and healthcare from the home. Bring new treatments to
market faster and at lower cost with the spencer® Smart Hub.
Spencer Health Solutions, Inc.’s award-winning spencer® Smart Hub
combines medication dispensing, telehealth and engagement so
patients, their health care providers, and clinical research teams
stay connected. For more information, visit
www.spencerhealthsolutions.com. Follow us on Twitter
@spencerhealth
- Spencer_Philips_1
- Spencer_Philips_2
Grafico Azioni Koninklijke Philips NV (BIT:1PHIA)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Koninklijke Philips NV (BIT:1PHIA)
Storico
Da Apr 2023 a Apr 2024
